2m 2m 2m 2m 2m 2m 2m
FENNEC PHARMA (FENC)
NASDAQ
$11.44+$0.15 (+1.35%)
Price as of Aug 21, 2026 7:56 PM EDT- $395.8MMarket Cap
- 30.37%1-Year Change
- BiotechnologyIndustry
FENNEC PHARMA (FENC)
$11.44+$0.15 (+1.35%)
FENC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.29 | ||
Change | -$0.06 (-0.53%) | ||
Open | $11.47 | ||
High | $11.65 | ||
Low | $11.22 | ||
Previous Close | $11.35 | ||
Volume | 210,738 | ||
30-Day Average Volume | 182,718 | ||
1-Week Change | -3.67% | ||
1-Month Change | 8.66% | ||
1-Year Change | 30.37% | ||
3-Year Change | 44.93% | ||
5-Year Change | 61.98% | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $75.8M | ||
Market Cap | $395.8M | ||
Enterprise Value | $354.6M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | $2.0M | ||
Free Cash Flow | $50,000.00 | ||
EBIT | $2.0M | ||
EBITDA | $2.0M | ||
Net Working Capital | $60.1M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 174 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 9 | ||
P/E | 226 | ||
PEG | 1 | ||
Price/Free Cash Flow | 7,916 | ||
Price/Operating Cash Flow | 7,916 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue